So it’s our first HOT TOPIC
The convalescent plasma arm of @remap_cap
Currently on channel 1 at #lives2021
@remap_cap Preprint available here
medrxiv.org/content/10.110…
#foamed #FOAMcc #LIVES2021
@remap_cap Inclusion criteria below
Intervention: 2u convalescent plasma vs standard care
@remap_cap Patient demographics and primary outcome (composite outcome)
No benefit seen in this study
@remap_cap Secondary outcomes/subgroup analysis
#lives2021
@remap_cap Conclusion #lives2021
There will be a subgroup study in the immunosuppressed- watch this space...
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.